Overview
Current Appointments & Affiliations
Adjunct Professor in the Department of Medicine
·
2017 - Present
Medicine, Medical Oncology,
Medicine
Recent Publications
Phase Ib/II study of Pembrolizumab with Lanreotide depot for advanced, progressive Gastroenteropancreatic neuroendocrine tumors (PLANET).
Journal Article J Neuroendocrinol · February 11, 2025 While performing a study of immune checkpoint blockade with the anti-PD-1 antibody pembrolizumab combined with the somatostatin analogue (SSA) lanreotide in patients with low- and intermediate-grade gastroenteropancreatic neuroendocrine tumors (GEP-NETs), ... Full text Link to item CiteCharacterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants.
Journal Article Cancer Epidemiol Biomarkers Prev · January 9, 2025 BACKGROUND: Biomarker analyses are an integral part of cancer research. Despite the intense efforts to identify and characterize biomarkers in patients with cancer, little is known regarding the natural variation of biomarkers in healthy populations. Here ... Full text Link to item CitePrognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis.
Conference Eur J Cancer · August 2024 BACKGROUND: The liver is the most frequent site of metastases in colorectal cancer (CRC). This study aimed to assess the response rate and survival outcomes in metastatic CRC patients with non-liver metastases (NLM) compared to those with liver metastases ... Full text Link to item CiteRecent Grants
A randomized double blind studyh of Ruxolitinib or placebo in combination with Regorafenib in subjects with relapsed or refractory metastatic colorectal cancer.
Clinical TrialPrincipal Investigator · Awarded by Incyte Corporation · 2014 - 2019A Companion study for patient who completed participation in a REGN2810 study
Clinical TrialPrincipal Investigator · Awarded by Regeneron Pharmaceuticals, Inc. · 2016 - 2018A Phase 2 randomized proff of concept study of Nab-Paclitaxel/Gemcitabine alone and in combination with ACP-196 in subjects with previously untreated metastatic pancreatic cancer.
Clinical TrialPrincipal Investigator · Awarded by Acerta Pharma · 2015 - 2017View All Grants
Education, Training & Certifications
Thomas Jefferson University ·
1988
M.D.